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ABSTRACT2
Purpose. The purpose of this study is classifying multiple sclerosis (MS) patients in the four3
clinical forms as defined by the McDonald criteria using machine learning algorithms trained on4
clinical data combined with lesion loads and magnetic resonance metabolic features.5
Materials and Methods. Eighty-seven MS patients (12 Clinically Isolated Syndrome (CIS), 306
Relapse Remitting (RR), 17 Primary Progressive (PP) and 28 Secondary Progressive (SP)) and7
eighteen healthy controls were included in this study. Longitudinal data available for each MS8
patient included clinical (e.g. age, disease duration, Expanded Disability Status Scale), conven-9
tional magnetic resonance imaging and spectroscopic imaging. We extract N-acetyl-aspartate10
(NAA), Choline (Cho), and Creatine (Cre) concentrations, and we compute three features for11
each spectroscopic grid by averaging metabolite ratios (NAA/Cho, NAA/Cre, Cho/Cre) over good12
quality voxels. We built linear mixed-effects models to test for statistically significant differences13
between MS forms. We test nine binary classification tasks on clinical data, lesion loads, and14
1
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metabolic features, using a leave-one-patient-out cross-validation method based on 100 ran-15
dom patient-based bootstrap selections. We compute F1-scores and BAR values after tuning16
Linear Discriminant Analysis (LDA), Support Vector Machines with gaussian kernel (SVM-rbf),17
and Random Forests.18
Results. Statistically significant differences were found between the disease starting points of19
each MS form using four different response variables: Lesion Load, NAA/Cre, NAA/Cho, and20
Cho/Cre ratios. Training SVM-rbf on clinical and lesion loads yields F1-scores of 71-72% for21
CIS vs. RR and CIS vs. RR+SP, respectively. For RR vs. PP we obtained good classification22
results (maximum F1-score of 85%) after training LDA on clinical and metabolic features, while23
for RR vs. SP we obtained slightly higher classification results (maximum F1-score of 87%) after24
training LDA and SVM-rbf on clinical, lesion loads and metabolic features.25
Conclusions. Our results suggest that metabolic features are better at differentiating between26
relapsing-remitting and primary progressive forms, while lesion loads are better at differen-27
tiating between relapsing-remitting and secondary progressive forms. Therefore, combining28
clinical data with magnetic resonance lesion loads and metabolic features can improve the29
discrimination between relapsing-remitting and progressive forms.30
Keywords: multiple sclerosis, longitudinal analysis, magnetic resonance spectroscopic imaging, EDSS, lesion load, machine learning31
1 INTRODUCTION
Multiple sclerosis (MS) is an inflammatory disorder of the brain and spinal cord in which focal lymphocy-32
tic infiltration leads to damage of myelin and axonsCompston and Coles (2008). MS affects approximately33
2.5 million people worldwide, with an onset age commonly between 20 and 40 years, and an incidence34
more than twice as high in women compared to menMcAlpine and Compston (2005).35
The majority of MS patients (85%) usually experience a first attack defined as Clinically Isolated Syn-36
drome (CIS), and will develop a relapsing-remitting (RR) formMiller et al. (2012). Two thirds of the37
RR patients will develop a secondary progressive (SP) form, while the other third will follow a benign38
courseScalfari et al. (2010). The rest of MS patients (15%) will start directly with a primary progressive39
(PP) form.40
The criteria to diagnose MS forms was originally formulated by McDonald in 2001McDonald et al.41
(2001) and revised by Polman in 2005Polman et al. (2005) and 2011Polman et al. (2011). They all rely42
on using conventional magnetic resonance imaging techniques (MRI) such as T1-weighted, gadolinium-43
enhanced T1-weighted MRI, as well as T2-weighted and FLAIR, due to a high sensitivity for visualizing44
MS lesions. Conventional MRI is also used for quantifying lesion load (LL), a marker of inflammation45
process but only a moderate predictor of MS evolutionFilippi et al. (1994).46
More recently, advanced magnetic resonance techniques such as 1H-Magnetic Resonance Spectrosco-47
pic Imaging (MRSI), Diffusion Tensor Imaging (DTI) and Magnetization Transfer Imaging (MTI) have48
been shown Rovira et al. (2013) to provide a better characterization of the normal appearing white matter49
(NAWM) and thus a better understanding of the pathological mechanisms of MS. MTI metrics reflect the50
demyelination and remyelination processes and have been shown to predict the evolution of MS lesions.51
DTI metrics are very sensitive to the MS pathology and have been shown to be mainly affected by mye-52
lin loss and decreased neuronal integrity. MRS metrics provide high MS pathological specificity as well53
as high sensitivity to biochemical changes. Decrease of N-acetyl-aspartate (NAA) was observed in both54
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chronic lesions and NAWM, reflecting a neuronal integrity lossRovira et al. (2013). Choline (Cho) and55
Creatine (Cre) contents were found to be increased in WM lesions and in NAWM, indicating the prese-56
nce of severe demyelination and cell proliferation in relation with inflammatory processesTartaglia et al.57
(2002); Sajja et al. (2009).58
Therefore, in this study we investigate the added value of magnetic resonance metabolic features59
(NAA/Cho, NAA/Cre, Cho/Cre) combined with routinely collected clinical MS data (e.g. patient age,60
disease duration (DD), Expanded Disability Status Scale (EDSS)) and lesion load values (LL). To this pur-61
pose, we build multiple binary classifiers to automatically discriminate between different clinical forms62
of MS patients, by training each classifier on combinations of clinical data, lesion loads and metabolic63
features.64
2 MATERIALS AND METHODS
2.1 Patient population65
Eighty-seven MS patients (12 CIS, 30 RR, 28 SP and 17 PP) were included in this study, while 1866
volunteers without any neurological disorders served as healthy control (HC) subjects. Diagnosis and67
disease course were established according to the McDonald criteria Lublin et al. (1996); McDonald et al.68
(2001). This prospective study was approved by the local ethics committee (CPP Sud-Est IV) and the69
French national agency for medicine and health products safety (ANSM) and written informed consents70
were obtained from all patients and control subjects prior to study initiation. More details for each MS71
group, such as average age at first scan, average disease duration, median EDSS and average lesion loads72
can be found in Table 1.73
CIS RR PP SP
Number of patients (Male/Female) 12 (6/6) 30 (6/24) 17 (6/11) 28 (17/11)
Age at first scan [years] 31.8 (6.4) 33.2 (7) 39.5 (6) 41.1 (4.8)
Disease duration [years] 2.9 (1.9) 8.3 (4.8) 7.5 (2.9) 14.9 (6.1)
EDSS median [range] 1 (0-4) 2 (0-5.5) 4 (2-7.5) 5 (3-8.5)
Lesion Load [ml] 6.6 (3.5) 16.7 (12.6) 20.8 (13) 31 (12.9)
Total number of scans 62 226 125 206
Table 1. Patient population: Age - average value (standard deviation); Disease duration - average value
(standard deviation); EDSS - median (minimum - maximum); Lesion Load - average value (standard
deviation).
2.2 Longitudinal MS data74
The MS patients involved in this study were scanned multiple times over a different period for each75
patient, ranging from 2.5 to 6 years. The minimum number of scans is 3, while the maximum is 10. The76
gap between two consecutive scans is either 6 months or 1 year. In total there are 619 MS scans, but77
because of missing lesion loads and metabolic features, there are 592 (95.6%) scans with full complete78
data, leading to an average of 6-7 complete scans/patient.79
2.3 MRI acquisition and processing80
All patients and control subjects underwent MR examination using a 1.5 Tesla MR system (Sonata81
Siemens, Erlangen, Germany) and an 8 elements phased-array head-coil.82
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2.3.1 Conventional MRI83
Conventional MRI protocol consisted of a 3 dimensional T1-weighted (magnetization prepared rapid84
gradient echo-MPRAGE) sequence with repetition time/echo time/time for inversion (TR/TE/TI)=85
1970/3.93/1100 ms, flip angle= 15°, matrix size= 256 × 256, field of view (FOV)= 256 × 256 mm,86
slice thickness= 1 mm, voxel size= 1 × 1 × 1 mm, acquisition time= 4.62 min, and a fluid attenuated87
inversion recovery (FLAIR) sequence with TR/TE/TI= 8000/105/2200 ms, flip angle= 150°, matrix88
size= 192× 256, field of view (FOV)= 240× 240 mm, slice thickness= 3 mm, voxel size= 0.9× 0.9× 389
mm, acquisition time= 4.57 min.90
2.3.2 MRSI acquisition91
MRSI data was acquired from one slice of 1.5 cm thickness, placed above the corpus callosum and92
along the anterior commissure - posterior commissure (AC-PC) axis, encompassing the centrum semio-93
val region, and took 5 minutes and 20 seconds. A point-resolved spectroscopic sequence (PRESS) with94
TR=1690 ms and TE=135 ms was used to select a volume of interest (VOI) of 105 × 105 × 15 mm395
during the acquisition of 24× 24 (interpolated to 32× 32) phase-encodings over a field of view (FOV) of96
240× 240 mm2.97
2.3.3 MRSI processing98
MRSI data processing was performed using SPID Poullet (2008); Poullet et al. (2008) in MatLab 2015a99
(MathWorks, Natick, MA, USA). AQSES-MRSI Poullet et al. (2007); Sava et al. (2011) was used to100
quantify N-acetyl-aspartate, Choline (Cho), and Creatine (Cre), using a synthetic basis set. The basis101
set incorporates prior knowledge of the individual metabolites in the quantification procedure. MPFIR102
(maximum-phase finite impulse response) filtering Sundin et al. (1999) was included in the AQSES-103
MRSI procedure for residual water suppression, with a filter length of 50 and spectral range from 1.9 to104
3.4 ppm. A band of two voxels at the outer edges of each VOI was discarded in order to avoid chemical105
shift displacement artifacts and lipid contamination artifacts.106
2.3.4 Quality control107
After quantifying metabolites from all MRSI grids, a quality control was performed. Voxels with108
Cramer-Rao Lower Bounds (CRLBs) lower than 10% for each of the three metabolites (NAA, Cho, and109
Cre) were kept as having “good quality” to perform feature extraction. If the number of “good quality”110
voxels is lower than 50% of the total amount of voxels in the MRSI grid, then the acquisition is discarded.111
All 18 Control subjects had MRSI data with a number of “good quality” voxels higher than 50% of the112
total amount of voxels, and 606 out of 619 (97.9%) MRSI data from MS patients had good quality as113
defined earlier.114
2.4 Feature extraction115
In this study we use three types of features: clinical (e.g. patient age, disease duration, and EDSS), lesion116
loads, and metabolic features. The clinical features are routinely acquired in the hospital. The lesion loads117
were computed based on T1 and FLAIR, using the MSmetrix software Jain et al. (2015) developed by118
icometrix (Leuven, Belgium). The computation of metabolic features was performed in two steps: three119
metabolic ratios (NAA/Cho, NAA/Cre, Cho/Cre) were computed for each “good quality” voxel and then120
averaged, leading to three metabolic features extracted from each MRSI grid.121
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2.5 Training approach122
Nine binary classification tasks were studied: HC vs. CIS, HC vs. RR, HC vs. PP, HC vs. RR+SP, HC123
vs. PP+SP, CIS vs. RR, CIS vs. RR+SP, RR vs. PP, RR vs. SP. The first three tasks investigated differences124
between HC and the starting MS forms (CIS, RR, and PP). The next task investigated differences between125
HC and MS patients that are likely to evolve or had evolved into secondary progressive form (RR+SP).126
Afterwards, we investigated differences between HC and definite progressive forms (PP+SP). The next127
two tasks investigated differences between CIS patients and the most likely progression of CIS, namely128
RR and RR+SP. From a neurological point of view, the last two tasks were the most intriguing, as they129
were discriminating between the most common inflammatory MS form (RR) and the two progressive130
forms, PP and SP.131
For each task, data normalization was performed. We use a leave-one-patient-out cross-validation132
(LOPOCV) setup combined with 100 random patient-based bootstrap selections for the training set. In133
this way, the test set has all data points of one patient, while the training set has n − 1 data points cor-134
responding to n − 1 patients, where n is the total number of patients, different for each classification135
task (e.g. for HC vs. CIS, n = 30). Basically, to construct the training set, we randomly select one data136
point from each patient assigned to the training set. The test set always includes all data points of the test137
patient. We repeat the procedure 100 times and store the results. Each data point from the test set will138
be assigned 100 times to either class 1 or class 2, and in the end it will be assigned to one of the classes139
according to majority voting. This procedure is repeated until all patients from each classification task140
have been tested.141
By using this random patient-based bootstrap selection, the two classes in the training set have a more142
balanced distribution of points (18 HC, 12 CIS, 30 RR, 17 PP, 28 SP), compared to using the total number143
of points of each class (18 HC, 61 CIS, 214 RR, 121 PP, 196 SP).144
2.6 Performance measures and statistical testing145
For each task, we computed and reported four measures, in percentage: F1-score, sensitivity, specificity,146
and balanced accuracy rate (BAR). We explain these four measures using the general confusion matrix in147
Table 2.148
Confusion matrix predicted conditionpredicted negative predicted positive
true condition condition negative true negative (TN) false positive (FP)condition positive false negative (FN) true positive (TP)
Table 2. General confusion matrix.
The four measures are defined by the following formulas: F1 = 2×TP2×TP+FN+FP , Sensitivity =149
TP
TP+FN , Specificity =
TN
TN+FP , BAR =
Sensitivity+Specificity
2 .150
Throughout our study the positive class was the first class from each of the nine binary classification151
tasks: HC for the first 5 tasks, CIS for the 6th and 7th tasks, and RR for 8th and 9th tasks.152
In order to correctly assess if there are significant differences between the four MS groups, we built153
several linear mixed effects models which were able to incorporate the temporal evolution of each patient’s154
MS course. We used five fixed effects and two random effects. The fixed effects are: MS course, gender,155
disease onset age, disease duration, and the interaction between MS course and disease duration. The156
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random effects are set for each patient allowing an individual starting point and an individual disease157
evolution. The most interesting fixed effect for this study is the first one, which represents the average158
of the response variable at the beginning of the MS course, or when ‘disease duration’ = 0. We built159
four linear mixed effects models, one for each response variable: NAA/Cho, NAA/Cre, Cho/Cre, and160
lesion load. All statistical models were built in the ‘R’ software using the “lme4” package Bates (2010),161
statistical testing was done using the “lmerTest” package Kuznetsova et al. (2015) and post-hoc analysis162
was done using the “multcomp” package Hothorn et al. (2008). All tests were done for a significance level163
(α) of 0.05.164
2.7 Classifiers165
Three supervised classifiers implemented in Python 2.7.11 with scikit-learn 0.17.1 Pedregosa et al.166
(2011) have been used: Linear Discriminant Analysis (LDA), Support Vector Machines (SVM), and Ran-167
dom Forest (RF). We tuned each classifier’s parameters by optimizing the F1-score over a 5-fold cross168
validation on the training set within a grid search of individual parameters, specified further for each169
particular classifier. Fisher’s LDA Fisher (1936) is based on a linear combination of input features, with170
three possible solvers: singular value decomposition, least squares solution, and eigenvalue decomposi-171
tion. Tuning involved choosing between the first solver and the last two solvers combined with shrinkage172
varying from 0 to 1 in steps of 0.1. Class unbalance was adjusted by setting the priors parameter equal to173
class probabilities. We use SVM Cortes and Vapnik (1995); Cristianini and Shawe-Taylor (2000) with a174
radial basis function kernel (SVM-rbf), defined by two parameters: C, or the misclassification cost, and175
γ, which is proportional to the inverse of a support vector’s radius of influence. We tuned C and γ by per-176
forming a logarithmic grid search between 0.00001 and 100000. Class unbalance was adjusted by setting177
the class weight parameter to balanced. Random Forests Breiman (2001) is based on a group of decision178
trees. We tune the number of decision trees between 200, 400, 600, 800, and 1000. Class unbalance was179
adjusted by setting the class weight parameter to balanced subsample.180
3 RESULTS
Figure 1 shows boxplots comparing MR metabolic features (A, B, C) and lesion loads (D) extracted from181
HC and each MS course. Boxplots are drawn using default style in MatLab, meaning the middle line182
inside the box represents the median value, the vertical limits are the 25th and 75th percentiles (q1 and183
q3), each whisker covers 1.5 the interquartile range (i.e. q3−q1), and the crosses outside the whiskers184
represent outliers. Figures 2, 3, 4, and 5 from Appendix show the MS data points in various 2-D feature185
spaces.186
Using the previously described (Section 2.6) linear mixed-effects models we found that the fixed effect187
MS course is statistically significant in the evolution of NAA/Cho, NAA/Cre, Cho/Cre, and LL, with188
corresponding p-values of: 3.4× 10−6, 2× 10−4, 2.3× 10−2, and 2.6× 10−4. Table 3 provides adjusted189
p-values for multiple comparisons between the MS groups.190
Table 4 shows F1-scores after training LDA using only metabolic ratios, as clinical data and lesion loads191
were not available for healthy controls. Corresponding BAR, sensitivity and specificity values of this table192
can be found in Table 6 in Appendix. If F1-scores are missing, then the classifier assigned all data points193
to the negative class (second MS group).194
Surprisingly, the F1-scores for separating HC from any MS course are very low, and the same holds true195
for separating very early MS form (CIS) and the most likely MS evolution, RR and RR+SP. In contrast,196
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Figure 1. Boxplots of MR metabolic features and lesion loads extracted from HC and MS patients: A.
NAA/Cho; B. NAA/Cre; C. Cho/Cre; D. Lesion load (LL).
CIS - RR RR - PP RR - SP
NAA/Cho - ** **
NAA/Cre - - *
Cho/Cre - - -
LL - - *
Table 3. Adjusted p-values for multiple comparisons between MS groups modelled by linear mixed
effects model, tested using the “multcomp” package in ‘R’ (* for p < 0.05 and ** for p < 0.01).
NAA/Cho NAA/Cre Cho/Cre All 3 metabolic ratios
HC vs. CIS 35 33 43 36
HC vs. RR 6 16 - 14
HC vs. PP 47 45 19 49
HC vs. RR+SP 8 19 - 16
HC vs. PP+SP 21 26 - 28
CIS vs. RR 15 - - 21
CIS vs. RR+SP 3 - - 19
RR vs. PP 75 78 75 74
RR vs. SP 60 67 58 69
Table 4. F1-scores for all nine classification tasks (rows) after training LDA using only metabolic ratios.
Values above 75 are coloured in light gray.
for RR vs. PP we find that all three metabolic ratios have F1-scores higher than 75, with a maximum197
of 78 for NAA/Cre. For RR vs. SP the F1-scores are lower, with a maximum of 69 after combining all198
metabolic features.199
Table 5 shows F1-scores of classification tasks involving only MS patients. Training was done on seven200
different combinations of features to evaluate the classification power of clinical data, lesion loads, and201
metabolic features. Corresponding BAR, sensitivity, and specificity values can be found in Appendix in202
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Tables 7, 8, and9, respectively. If F1-scores are missing, then the classifier assigned all data points to the203
negative class (second MS group).204
CIS vs. RR CIS vs. RR+SP RR vs. PP RR vs. SP
LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF
M 21 48 11 19 31 - 74 52 73 69 70 67
LL - 51 27 - 40 24 71 19 73 75 77 68
Age + DD 48 58 51 44 56 50 79 64 74 76 75 71
Age + DD + EDSS 55 65 49 57 66 48 85 81 79 84 85 84
Age + DD + EDSS + LL 67 71 59 63 72 60 79 75 79 86 86 86
Age + DD + EDSS + M 56 59 48 60 59 51 85 83 80 86 87 85
Age + DD + EDSS + LL + M 65 64 57 65 63 57 83 81 78 87 87 86
Table 5. F1-scores for classification tasks involving only MS patients (columns). Abbreviations: M = all
three average metabolic ratios; Age = patient age; DD = disease duration; LL = lesion load; EDSS =
Expanded Disability Status Scale. Values between 75 and 79 are coloured in light gray, values between
80 and 84 are coloured in medium gray, while values larger than 85 are coloured in dark gray.
The highest F1-scores for CIS vs. RR and CIS vs. RR+SP, respectively 71 and 72, were achieved by205
SVM-rbf trained on clinical data and lesion loads. Training any classifier only on metabolic features206
yielded very low F1-scores.207
The highest F1-score for RR vs. PP (85) was achieved by LDA using patient age, disease age, and EDSS.208
Adding all spectroscopic information maintained the F1-score at 85, while adding lesion load lowered the209
F1-score at 79. LDA outperformed SVM-rbf and RF in all RR vs. PP cases, always achieving an F1-score210
higher than 70.211
The highest value for RR vs. SP (87) was first achieved after training SVM-rbf on clinical and metabolic212
features, but also with LDA trained on all features combined (clinical data, lesion loads, and metabolic213
features). SVM-rbf outperfomed LDA in the majority RR vs. SP cases, but only with 1 to 2%.214
4 DISCUSSION
In this paper, we present results for nine binary classification problems using clinical data, lesion loads215
and metabolic features extracted from MS patients and healthy controls. We focused on metabolic features216
as numerous studies showed significant metabolic alterations in MS patients of different MS forms. It has217
been demonstrated that metabolic abnormalities in MS patients are not restricted to lesions alone Narayana218
et al. (1998); Doyle et al. (1995); He et al. (2005); Fu et al. (1998); Husted et al. (1994); Narayanan et al.219
(1997); Sarchielli et al. (1999) and NAWM tissue is well known to be altered in MS Narayana (2005);220
De Stefano and Filippi (2007). Concentrations of NAA in NAWM were shown to be significantly lower221
in MS patients Bitsch et al. (1999); Bjartmar et al. (2001); Tiberio et al. (2006); Inglese et al. (2003);222
Suhy et al. (2000); Wattjes et al. (2007, 2008). Concentrations of Cho and Cre in NAWM were shown223
to be significantly higher in MS patients Narayana et al. (1998); Tartaglia et al. (2002); Inglese et al.224
(2003); Tourbah et al. (1999); Suhy et al. (2000). Concentrations of NAA/Cre in NAWM were shown to225
be significantly lower in MS patients Leary et al. (1999); Narayana et al. (2004). Multiple studies also226
report significant differences between metabolite concentrations in lesions vs. NAWM of HC: lower NAA227
and increased Cho and Cre Narayana et al. (1998); Davie et al. (1997); He et al. (2005); Arnold et al.228
(2000); Wolinsky et al. (1990); Larsson et al. (1991); Davie et al. (1994).229
Our findings are in agreement with these previous reports as decreased NAA and increased Cho and Cre230
contents were measured in NAWM and lesions of MS patients. After building linear mixed-effects models231
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to properly analyze the statistical difference between the four clinical courses, we observed significant232
differences at the disease starting points of all MS courses using four response variables, namely the lesion233
load, NAA/Cre, NAA/Cho, and Cho/Cre ratios. A cross-sectional study Hannoun et al. (2012) based on a234
subset of our MRSI data found statistical differences in the NAA/Cre and NAA/Cho ratios between HC235
and RR, PP, SP, and RR+PP+SP patients. To our knowledge, there is only one study that reports sensitivity236
and specificity values for classifying healthy controls from MS patients based on spectroscopic features.237
Inglese et al. show in Inglese et al. (2003) that absolute values of choline in NAWM can differentiate 9238
controls and 10 out of 11 RR patients.239
Other MS classification studies are Muthuraman et al. (2016) and Kocevar et al. (2016), both based240
on diffusion features. The first one reports a classification accuracy of 97% between 20 CIS and 33 RR241
patients. The second one analyzes classification tasks based on DTI data from a cross-sectional subset of242
our database. They found very high F1-scores (91.8% for both HC-CIS and CIS-RR) after training SVM-243
rbf on six global brain connectivity metrics. For RR vs. PP their maximum F1-score was 75.6%, which244
is lower than our results based on metabolic features, while for RR vs. SP, their maximum F1-score was245
85.5%, which is comparable to our results. It is also worth mentioning that they did not use any clinical246
data, which might improve their results.247
In this study, we analyzed the added value of combining standard clinical data with quantitative magnetic248
resonance features. To this purpose, we trained linear and non-linear classifiers only on advanced MR249
features, and then only on clinical data. Afterwards we train the classifiers on clinical data combined with250
lesion loads and metabolic features.251
Although MS patients are expected to have significantly different WM metabolism compared to healthy252
controls, this difference was not reflected in the metabolic average obtained from “good quality” voxels253
(Figure 2, A and B). This result is not entirely surprising, considering that we averaged over a high number254
of voxels, and the subtle lesion information could be lost in the average. However, we can visually see255
in Figure 2:C&D that the two progressive MS courses tend to have lower NAA/Cho and NAA/Cre ratios256
than healthy controls.257
CIS and RR patients’ distribution over the NAA/Cho and NAA/Cre feature space do not differ much, as258
seen in Figure 3:A. Disease duration interval for RR patients is much larger than for CIS patients, as most259
of CIS patients have a disease duration lower than 5 years, which can be seen in Figure 4:A. Because RR260
patients have more relapses than CIS patients, the number of lesions will be higher and the lesion volume261
as well, while EDSS scores are mainly in the same range, as seen in Figure 5:A. BAR values in Table 7262
show a maximum of 85, when combining patient age, disease duration, EDSS, and lesion load. However,263
the corresponding maximum F1-score of 71 is much lower because the dataset is unbalanced (61 CIS vs.264
214 RR), heavily influencing the classifier’s precision. In this case the F1-score reflects better than BAR265
the difficulty of discriminating CIS from RR forms.266
CIS and SP patients’ distribution over different features is visible in Figure 3:B, Figure 4:B, and267
Figure 5:B, and it is clear that these two are the least and most advanced forms of MS. Because RR268
patients will eventually evolve into SP forms during their lifetime, we grouped together RR and SP pati-269
ents for a separate classification task versus CIS patients. BAR values in Table 7 show a maximum of 92,270
when combining patient age, disease duration, EDSS and lesion load. The same discussion as for CIS vs.271
RR apply: the corresponding maximum F1-score is only 72 because the dataset is very unbalanced (61272
CIS vs. 410 RR+SP) and the precision will be very low.273
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RR and PP patients can be discriminated using only EDSS by visually inspecting Figure 5:C. Training274
a linear classifier on clinical data (patient age, disease duration, and EDSS) gives the maximum F1-score275
of 85. Adding the 3 metabolic features keeps the score at 85, while adding lesion load information lowers276
the score to 79. This drop in the F1-score suggests that lesion load is not useful in differentiating RR277
from PP patients. Indeed, these two MS forms have the closest lesion load averages (16.7 ml and 20.8278
ml), as shown in Table 1. In contrast, the clinical status of RR and PP patients are very different, as279
reflected by the EDSS values of 2 for RR and 4 for PP. Moreover, training LDA on individual metabolic280
features always provided higher F1-scores than lesion load, therefore we can conclude that for RR vs. PP,281
metabolic features have a higher discrimination power than LL. BAR values in Table 7 are also closer to282
the F1-scores in Table 5 because the dataset is more balanced compared to previous cases.283
RR and SP patients can also be discriminated using only EDSS by visually inspecting Figure 5:D. Our284
results showed that EDSS is very important in differentiating RR patients from primary or secondary285
progressive patients. We also report consistent higher F1-scores for classifiers trained only on lesion load286
compared to classifiers trained only on metabolic features. Furthermore, it is clearly visible in Table 4287
that we obtain higher F1-scores for this classification task using multiple features, compared to the rest of288
8 tasks. These findings suggest that in the future it might be possible to build a decision support system289
using clinical data combined with lesion loads and metabolic features.290
However, this study suffers from a few limitations, one of them being the low scanning frequency291
of only 1.5 Tesla. Firstly, it is known that the sensitivity of lesion load segmentation is improved by292
scanning at higher frequenciesSicotte et al. (2003). Therefore, our LL values may not reflect entirely293
the pathological changes inside the brain. Secondly, the signal to noise ratio of MRSI is proportional294
to the scanning frequency, meaning our metabolites’ quantification is not entirely accurate. Moreover,295
spectroscopic signal scales can differ from patient to patient, resulting in large metabolite variations. In296
order to obtain true metabolites concentrations, we would have to measure, for each patient, the T1 and297
T2 relaxation times for each metabolite, which would be impossible in clinical practice. To overcome298
some of these limitations, we use as features all three metabolite ratios (NAA/Cho, NAA/Cre, Cho/Cre).299
By doing so, we expect to retain sufficient valuable information to conduct our analysis.300
When comparing classification tasks from a computational point of view, LDA is clearly the winner as301
the training period last only 3 hours using a computer with 8 threads. Training both SVM-rbf and RF took302
around 20 days in total and it was done using 60 threads, meaning LDA is approximately 600 times faster303
than SVM-rbf or RF. Also, the maximum F1-scores for RR vs. PP and RR vs. SP were obtained with LDA304
and SVM-rbf, suggesting that a linear classifier performs equally good as a non-linear classifier in these305
cases.306
This study is a proof of concept that investigates the added value of MR metabolites combined with307
clinical data and lesion loads, in classifying MS patients and healthy controls. Clinical data is routinely308
collected by doctors, lesion load is a known marker of neurodegeneration, while MR metabolites have309
been shown to provide high specificity of MS pathology. In order to better understand the underlying MS310
pathological mechanisms, we used three different machine learning methods, one linear and two non-311
linear, and had a strict quality control for extracting metabolic features. Despite all our efforts, averaging312
metabolite ratios over “good quality” voxels provides only moderate biomarkers for discriminating MS313
groups (i.e. RR vs. PP). In general, combining patient age, disease duration, EDSS, and averaged meta-314
bolic ratios, leads to the highest classification results. We believe extracting metabolic information from315
specific brain sub-regions of the MRSI grid (e.g NAWM) should provide a more detailed view of MS316
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pathology and help the classification tasks. Therefore, further investigations about the MS patients’ evo-317
lution will be done in the future on sub-regions metabolite quantification, DTI-based brain connectivity318
metrics, patient treatment, and multi-class classification.319
5 CONCLUSIONS
In this paper, we performed nine binary classification tasks and report F1-scores and BAR values after320
learning linear and non-linear classifiers on combinations of clinical data, lesion loads, and metabolic321
features. We presented a simple method to compute metabolic features by averaging metabolite ratios over322
“good quality” voxels of a MRSI grid. Using linear mixed-effects models we found that the MS course323
is statistically significant in the evolution of four response variables: Lesion Load, NAA/Cre, NAA/Cho,324
and Cho/Cre ratios. Our results showed that the best classifier for discriminating CIS from RR or RR+SP325
is SVM-rbf trained on clinical data and lesion loads. We also showed that discriminating RR from PP or326
SP with high accuracy is possible when training LDA on clinical data. For RR vs. PP, adding metabolic327
features will not change the results, while for RR vs. SP, adding metabolic features and lesion loads will328
slightly improve the results.329
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7 APPENDIX
NAA/Cho NAA/Cre Cho/Cre All 3 metabolites
BAR SPE SEN BAR SPE SEN BAR SPE SEN BAR SPE SEN
HC vs. CIS 47 0 94 46 15 78 61 39 83 53 39 67
HC vs. RR 50 94 6 55 82 28 50 100 0 52 76 28
HC vs. PP 76 80 72 78 72 83 45 29 61 77 82 72
HC vs. RR + SP 52 98 6 60 92 28 50 100 0 59 90 28
HC vs. RR + PP 61 89 33 66 88 44 50 100 0 52 88 16
CIS vs. RR 52 95 10 50 100 0 50 99 0 52 88 16
CIS vs. RR + SP 51 100 2 49 99 0 50 100 0 54 94 15
RR vs. PP 59 37 81 63 38 88 48 2 95 63 49 77
RR vs. SP 57 53 62 65 62 69 39 0 79 66 62 70
Table 6. Balanced accurary rates (BAR), sensitivity (SEN), and specificity (SPE) values, for all 9 clas-
sification tasks (rows) after training LDA using only metabolic ratios. Values between 75 and 79 are
coloured in light gray, values between 80 and 84 are coloured in medium gray, values between 85 and 89
are coloured in dark gray, while values higher than 90 are coloured in very dark gray.
CIS vs. RR CIS vs. RR+SP RR vs. PP RR vs. SP
LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF
M 52 68 49 54 63 49 63 28 59 66 66 63
LL 48 70 52 50 73 56 43 12 58 74 75 68
Age + DD 66 75 68 66 83 70 67 38 62 75 76 71
Age + DD + EDSS 71 80 67 77 89 69 81 78 70 84 85 84
Age + DD + EDSS + LL 79 85 73 81 92 76 71 72 69 86 86 85
Age + DD + EDSS + M 72 76 66 81 82 70 80 81 71 86 87 84
Age + DD + EDSS + LL + M 78 80 71 82 83 73 78 78 68 86 86 86
Table 7. BAR values for classification tasks involving only MS patients (columns). Abbreviations: M =
all three average metabolic ratios; Age = patient age; DD = disease duration; LL = lesion load; EDSS =
Expanded Disability Status Scale.Values between 75 and 79 are coloured in light gray, values between 80
and 84 are coloured in medium gray, values between 85 and 89 are coloured in dark gray, while values
higher than or equal to 90 are coloured in very dark gray.
CIS vs. RR CIS vs. RR+SP RR vs. PP RR vs. SP
LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF
M 16 79 8 15 67 0 77 56 78 70 75 72
LL 0 80 30 0 80 23 87 16 78 77 80 67
Age + DD 41 77 49 36 84 46 84 75 78 74 70 70
Age + DD + EDSS 56 82 44 62 92 43 84 75 80 80 83 81
Age + DD + EDSS + LL 69 87 56 69 93 57 81 69 83 85 84 85
Age + DD + EDSS + M 59 74 41 74 79 44 84 76 82 84 85 84
Age + DD + EDSS + LL + M 67 79 49 72 77 51 83 75 81 87 87 86
Table 8. Sensitivity values for classification tasks involving only MS patients (columns). Abbreviations:
M = all three average metabolic ratios; Age = patient age; DD = disease duration; LL = lesion load; EDSS
= Expanded Disability Status Scale. Values between 75 and 79 are coloured in light gray, values between
80 and 84 are coloured in medium gray, values between 85 and 89 are coloured in dark gray, while values
higher than or equal to 90 are coloured in very dark gray.
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CIS vs. RR CIS vs. RR+SP RR vs. PP RR vs. SP
LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF LDA SVM-rbf RF
M 88 57 89 94 59 98 49 0 40 62 56 54
LL 96 60 75 100 66 89 0 7 37 70 70 69
Age + DD 91 74 87 96 83 94 50 0 46 76 82 72
Age + DD + EDSS 87 79 89 91 87 95 78 81 60 89 87 86
Age + DD + EDSS + LL 89 83 90 92 90 95 60 75 55 87 87 85
Age + DD + EDSS + M 85 78 91 89 86 95 75 86 60 88 88 84
Age + DD + EDSS + LL + M 88 81 93 92 89 96 74 82 56 85 86 85
Table 9. Specificity values for classification tasks involving only MS patients (columns). Abbreviations:
M = all three average metabolic ratios; Age = patient age; DD = disease duration; LL = lesion load; EDSS
= Expanded Disability Status Scale. Values between 75 and 79 are coloured in light gray, values between
80 and 84 are coloured in medium gray, values between 85 and 89 are coloured in dark gray, while values
higher than or equal to 90 are coloured in very dark gray.
Figure 2. HC vs. MS groups in 2-D feature space: x-axis is NAA/Cho and y-axis is NAA/Cre.
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Figure 3. Comparison of MS groups in 2-D feature space: x-axis is NAA/Cho and y-axis is NAA/Cre.
Figure 4. Comparison of MS groups in 2-D feature space: x-axis is disease age and y-axis is Cho/Cre.
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Figure 5. Comparison of MS groups in 2-D feature space: x-axis is lesion load and y-axis is EDSS.
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